Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Slepian to head MicroMed's scientific advisory board

This article was originally published in Clinica

Executive Summary

MicroMed Cardiovascular, the developer of the HeartAssist 5 left ventricular assist device (LVAD), has appointed Marvin Slepian as chairman of its scientific advisory board. Dr Slepian is the co-founder, chief medical and scientific officer and chairman of SynCardia Systems, the manufacturer of the world's first and only approved total artificial heart. Other members of MicroMed's scientific advisory board include Drs George Noon, coinventor of the HeartAssist 5, and Matthias Loebe, Professor at Baylor College of Medicine. The HeartAssist 5, also known as the Modern DeBakey VAD, is CE marked for both adult and paediatric use – in the US, it is approved only for paediatric use. The light-weight, miniature pump is one of the few devices of its kind that can be implanted above the diaphragm, adjacent to the heart. Unlike other LVADs, the HeartAssist 5 is said to be the only one that can offer precise, direct flow measurement.

You may also be interested in...

Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?

Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.

Roche Dx' EMEA Head To Take Charge After Diggelmann Departs

Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.

Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio

Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts